| Jeena Sikho Lifecare Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544476 |
NSE Symbol : JSLL |
P/E(TTM) : 37.16 |
|
ISIN Demat : INE0J5801029 |
Div & Yield% : 0.18 |
EPS(TTM) : 16.43 |
|
Book Value(₹) : 28.45 |
Market Cap(₹Cr) : 7,588.56 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 221.66 | 189.85 | 174.29 | 139.02 | 115.69 | 114.09 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 221.66 | 189.85 | 174.29 | 139.02 | 115.69 | 114.09 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.57 | 1.44 | 1.07 | 0.49 | 0.39 | 3.45 |
| Total Income | 224.23 | 191.29 | 175.35 | 139.51 | 116.08 | 117.54 |
| Total Expenditure | 120.87 | 97.78 | 95.50 | 92.30 | 86.08 | 73.82 |
| PBIDT | 103.37 | 93.51 | 79.86 | 47.21 | 30.00 | 43.72 |
| Interest | 3.10 | 4.35 | 1.66 | 1.53 | 3.79 | 2.07 |
| PBDT | 100.27 | 89.16 | 78.20 | 45.68 | 26.21 | 41.65 |
| Depreciation | 11.21 | 10.40 | 9.65 | 8.80 | 8.47 | 6.25 |
| Tax | 23.98 | 20.52 | 17.78 | 10.07 | 5.68 | 9.89 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.65 | -0.55 | -0.54 | -0.54 | -1.15 | -1.08 |
| Reported Profit After Tax | 66.73 | 58.79 | 51.31 | 27.35 | 13.21 | 26.60 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 66.73 | 58.79 | 51.31 | 27.35 | 13.21 | 26.60 |
| EPS (Unit Curr.) | 5.37 | 4.73 | 4.13 | 2.20 | 1.06 | 2.14 |
| EPS (Adj) (Unit Curr.) | 5.37 | 4.73 | 4.13 | 0.44 | 0.21 | 0.43 |
| Calculated EPS (Unit Curr.) | 5.37 | 4.73 | 4.13 | 2.20 | 1.06 | 2.14 |
| Calculated EPS (Adj) (Unit Curr.) | 5.37 | 4.73 | 4.13 | 0.44 | 0.21 | 0.43 |
| Calculated EPS (Ann.) (Unit Curr.) | 21.47 | 18.92 | 16.51 | 8.80 | 4.25 | 8.56 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 21.47 | 18.92 | 16.51 | 1.76 | 0.85 | 1.71 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 46.63 | 49.25 | 45.82 | 33.96 | 25.93 | 38.32 |
| PBDTM(%) | 45.24 | 46.96 | 44.87 | 32.86 | 22.66 | 36.51 |
| PATM(%) | 30.10 | 30.97 | 29.44 | 19.67 | 11.42 | 23.31 |
